1. Home
  2. KULR vs EMBC Comparison

KULR vs EMBC Comparison

Compare KULR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KULR Technology Group Inc.

KULR

KULR Technology Group Inc.

HOLD

Current Price

$3.83

Market Cap

176.2M

Sector

Technology

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.10

Market Cap

200.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KULR
EMBC
Founded
2013
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.2M
200.5M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
KULR
EMBC
Price
$3.83
$3.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
3.1M
1.9M
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
$1,274,028.00
N/A
Revenue This Year
$123.93
$1.17
Revenue Next Year
$63.38
N/A
P/E Ratio
N/A
$4.60
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$2.77
52 Week High
$7.49
$15.55

Technical Indicators

Market Signals
Indicator
KULR
EMBC
Relative Strength Index (RSI) 49.97 26.12
Support Level $3.03 $2.77
Resistance Level $4.47 $3.48
Average True Range (ATR) 0.51 0.17
MACD -0.15 0.18
Stochastic Oscillator 18.25 14.42

Price Performance

Historical Comparison
KULR
EMBC

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices. The Company operated two segments -EMP and Mining of Digital Assets.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: